ImmunityBio IBRX
NASDAQ IBRX
$8.83 +0.31 (+3.64%)
At close: Sep 29, 2026 · 4:00 PM EDT

ImmunityBio (IBRX) Notes Payables (2014 - 2023)

Updated

ImmunityBio's Notes Payables came in at $481.89 million for Q2 2023, up 60.6% from $300.08 million a year earlier and up 2.2% from the prior quarter.

Analysis

ImmunityBio (IBRX) Notes Payables (2014 - 2023) Analysis & Trends

At the end of FY2022, ImmunityBio's Notes Payables was $431.9 million, up 44.3% from FY2021.

  • Going back by year, Notes Payables was $299.24 million in FY2021.
  • The Q2 2023 figure represents the highest quarterly Notes Payables in data going back to Q4 2014.
  • Year-over-year, Notes Payables has increased for three consecutive quarters.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 ImmunityBio 8.97 Bn 7.74 Bn 50.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 481.89 Mn
Mar 31, 2023 471.48 Mn
Dec 31, 2022 431.90 Mn
Jun 30, 2022 300.08 Mn
Mar 31, 2022 299.61 Mn
Dec 31, 2021 299.24 Mn
Sep 30, 2015 675,000.00
Jun 30, 2015 675,000.00
Dec 31, 2014 265,000.00
API Access

ImmunityBio Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=IBRX&period=max&api_key=YOUR_API_KEY